Head of Autoimmune Diabetes T1D Italy Location: Milan Job type: Permanent, Full-time About the role As Head of Autoimmune Diabetes T1D Italy , you will lead the launch in Italy of this breakthrough therapy. You'll drive commercial strategy, build health system readiness, and help redefine the standard of care in preventive medicine — all while working in one of pharma's most dynamic and high-visibility spaces.
You will report directly to the General Manager and also be a member of the GenMed Italy leadership team, having a meaningful impact above your T1D franchise Head role and supporting the vision and ambition of the entire GBU in Italy. Ready to get started ? About Sanofi: At Sanofi, we chase the miracles of science to improve people's lives.
Tzield/Teizeild — our first-in-class, disease-modifying therapy for Autoimmune Type 1 Diabetes — is re-defining the way we used to manage T1D. Approved in the US, EU, UK, China, Canada, Australia and beyond, it delays the onset of stage 3 T1D and gives patients and families more time and hope.




Our target is to launch it in Italy by mid-2027. Key Responsibilities : Lead the T1D team to launch successfully Tzield/Teizeild in the Italyco-build the Integrated Growth Plan with Global, translate insights into local execution, and track performance through meaningful KPIs Collaborate cross-functionally (e.g., Medical, Market Access, Public Affairs, Communications) — define a broad stakeholder engagement strategy by understanding how stakeholders impact each other in ecosystem (e.g., COEs, KOLs, HCPs, DOLs, scientific societies, PAGs, policy makers, payers, think-tanks, etc.) and tailor engagement to their level of maturity in T1D journey Adapt and execute Glocal state of the art — multi-factorial stakeholder engagement to local context (incl. Omnichannel with compelling narrative/content) Secure optimal market access for Teizeild — obtain the best access that reflects its therapeutic innovation Drive treatment launch uptake — supp

📌 Autoimmune Type 1 Diabetes Franchise Head Italy (Milano)
🏢 Sanofi-Aventis Deutschland
📍 Milano